Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants

Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants

Waned vaccine-induced immunity and emerging severe acute respiratory syndrome coronavirus 2 variants with potential for immune escape pose a major threat to the coronavirus disease (COVID-19) pandemic. Here, we showed that humoral immunity components, including anti-S + N, anti-RBD IgG, and neutrali...

Full description

Bibliographic Details
Main Authors: Zhuxiang Zhao, Tingting Cui, Mingzhu Huang, Shuo Liu, Xiaoling Su, Guichang Li, Tao Song, Weidong Li, Nanshan Zhong, Miao Xu, Xiaoyun Yang, WeiJin Huang, Zhongfang Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Emerging Microbes and Infections
Subjects:
COVID-19 vaccine
prime-boost strategy
neutralizing antibody
T cell response
heterologous boosting
subunit vaccine
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2048969

Similar Items

Similar Items